Published in Antimicrob Agents Chemother on December 01, 2001
The TetR family of transcriptional repressors. Microbiol Mol Biol Rev (2005) 6.02
The versatility and adaptation of bacteria from the genus Stenotrophomonas. Nat Rev Microbiol (2009) 3.00
Regulation of bacterial drug export systems. Microbiol Mol Biol Rev (2002) 3.00
The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev (2015) 1.81
Diffusible signal factor-dependent cell-cell signaling and virulence in the nosocomial pathogen Stenotrophomonas maltophilia. J Bacteriol (2007) 1.79
Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin Microbiol Rev (2012) 1.74
SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2002) 1.60
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system. Antimicrob Agents Chemother (2010) 1.50
Cloning and characterization of SmeT, a repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF. Antimicrob Agents Chemother (2002) 1.34
Mutations in PA2491 (mexS) promote MexT-dependent mexEF-oprN expression and multidrug resistance in a clinical strain of Pseudomonas aeruginosa. J Bacteriol (2005) 1.29
Molecular cloning and characterization of an ABC multidrug efflux pump, VcaM, in Non-O1 Vibrio cholerae. Antimicrob Agents Chemother (2003) 1.19
The biocide triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDEF multidrug efflux pump. Antimicrob Agents Chemother (2005) 1.17
The binding of triclosan to SmeT, the repressor of the multidrug efflux pump SmeDEF, induces antibiotic resistance in Stenotrophomonas maltophilia. PLoS Pathog (2011) 1.12
Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance. Infect Immun (2003) 1.07
Coordinate hyperproduction of SmeZ and SmeJK efflux pumps extends drug resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2012) 1.06
Heavy metal tolerance in Stenotrophomonas maltophilia. PLoS One (2008) 1.05
Structural and functional analysis of SmeT, the repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF. J Biol Chem (2009) 1.03
Contribution of resistance-nodulation-division efflux pump operon smeU1-V-W-U2-X to multidrug resistance of Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2011) 1.03
Mechanisms of drug resistance: quinolone resistance. Ann N Y Acad Sci (2015) 1.00
Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia. Front Microbiol (2015) 0.94
In vitro killing effect of moxifloxacin on clinical isolates of Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother (2002) 0.93
A function of SmeDEF, the major quinolone resistance determinant of Stenotrophomonas maltophilia, is the colonization of plant roots. Appl Environ Microbiol (2014) 0.93
Metabolic compensation of fitness costs associated with overexpression of the multidrug efflux pump MexEF-OprN in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2014) 0.92
Development and application of the active surveillance of pathogens microarray to monitor bacterial gene flux. BMC Microbiol (2008) 0.85
Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation. Front Oncol (2014) 0.83
Bacterial Multidrug Efflux Pumps: Much More Than Antibiotic Resistance Determinants. Microorganisms (2016) 0.79
Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms. Int J Environ Res Public Health (2015) 0.79
Antibiogram of Stenotrophomonas maltophilia Isolated From Nkonkobe Municipality, Eastern Cape Province, South Africa. Jundishapur J Microbiol (2014) 0.79
Multidrug Efflux Pumps at the Crossroad between Antibiotic Resistance and Bacterial Virulence. Front Microbiol (2016) 0.78
Vitamin K3 Induces the Expression of the Stenotrophomonas maltophilia SmeVWX Multidrug Efflux Pump. Antimicrob Agents Chemother (2017) 0.75
Genomic insights into the virulence and salt tolerance of Staphylococcus equorum. Sci Rep (2017) 0.75
Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science (1994) 11.18
Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol (1993) 8.95
Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 6.65
Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol (1997) 5.91
A functional-phylogenetic classification system for transmembrane solute transporters. Microbiol Mol Biol Rev (2000) 5.65
Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev (1998) 5.33
Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol Microbiol (1996) 5.20
Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother (1999) 4.57
Antibiotic resistance caused by gram-negative multidrug efflux pumps. Clin Infect Dis (1998) 3.85
Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli. J Bacteriol (1997) 3.81
An overview of the kinetic parameters of class B beta-lactamases. Biochem J (1993) 3.76
Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob Agents Chemother (2000) 3.22
Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983. Int J Syst Bacteriol (1993) 3.16
Genetic systems in Haemophilus influenzae. Methods Enzymol (1991) 3.13
Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis (2000) 2.40
Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2000) 2.17
Multiple antibiotic resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother (1997) 2.13
Role of the multidrug efflux systems of Pseudomonas aeruginosa in organic solvent tolerance. J Bacteriol (1998) 2.04
Rapid identification of metallo- and serine beta-lactamases. Antimicrob Agents Chemother (1994) 1.98
Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2001) 1.87
Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples. J Clin Microbiol (1998) 1.77
Genomic diversity of the genus Stenotrophomonas. Int J Syst Bacteriol (1999) 1.75
Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system. Antimicrob Agents Chemother (2000) 1.65
Characterization of the chromosomal aac(6')-Iz gene of Stenotrophomonas maltophilia. Antimicrob Agents Chemother (1999) 1.61
Molecular heterogeneity of the L-1 metallo-beta-lactamase family from Stenotrophomonas maltophilia. Antimicrob Agents Chemother (1998) 1.57
Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2001) 1.53
Xanthomonas maltophilia: an emerging nosocomial pathogen. Mayo Clin Proc (1989) 1.51
Outer membrane permeability and beta-lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants. Rev Infect Dis (1988) 1.21
Stenotrophomonas maltophilia in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis (1995) 1.21
Organic solvent-tolerant mutants of Pseudomonas aeruginosa display multiple antibiotic resistance. Can J Microbiol (1999) 1.10
Mutational analysis of the OprM outer membrane component of the MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa. J Bacteriol (2001) 1.07
Aminoglycoside 6'-N acetyltransferase production by an isolate of Pseudomonas maltophilia. J Antimicrob Chemother (1978) 0.90
The role of lipopolysaccharide anionic binding sites in aminoglycoside uptake in Stenotrophomonas (Xanthomonas) maltophilia. J Antimicrob Chemother (1995) 0.85
Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 6.65
Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol Microbiol (1996) 5.20
AiiA, an enzyme that inactivates the acylhomoserine lactone quorum-sensing signal and attenuates the virulence of Erwinia carotovora. Proc Natl Acad Sci U S A (2000) 4.18
Outer membrane protein P of Pseudomonas aeruginosa: regulation by phosphate deficiency and formation of small anion-specific channels in lipid bilayer membranes. J Bacteriol (1982) 2.73
Influence of the MexAB-OprM multidrug efflux system on quorum sensing in Pseudomonas aeruginosa. J Bacteriol (1998) 2.61
Monoclonal antibodies against Pseudomonas aeruginosa outer membrane antigens: isolation and characterization. Infect Immun (1982) 2.61
Inner membrane efflux components are responsible for beta-lactam specificity of multidrug efflux pumps in Pseudomonas aeruginosa. J Bacteriol (1997) 2.54
Are members of multidisciplinary teams in breast cancer aware of each other's informational roles? Qual Health Care (2001) 2.44
Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain. Antimicrob Agents Chemother (1998) 2.39
The outer membrane protein OprM of Pseudomonas aeruginosa is encoded by oprK of the mexA-mexB-oprK multidrug resistance operon. Antimicrob Agents Chemother (1995) 2.25
Contribution of outer membrane efflux protein OprM to antibiotic resistance in Pseudomonas aeruginosa independent of MexAB. Antimicrob Agents Chemother (1998) 2.14
Role of the multidrug efflux systems of Pseudomonas aeruginosa in organic solvent tolerance. J Bacteriol (1998) 2.04
Influence of mutations in the mexR repressor gene on expression of the MexA-MexB-oprM multidrug efflux system of Pseudomonas aeruginosa. J Bacteriol (2000) 1.98
Beta-lactamase inhibitors are substrates for the multidrug efflux pumps of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1998) 1.96
Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother (2001) 1.96
MexR repressor of the mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosa: identification of MexR binding sites in the mexA-mexR intergenic region. J Bacteriol (2001) 1.86
Tomographic 3D reconstruction of quick-frozen, Ca2+-activated contracting insect flight muscle. Cell (1999) 1.85
Cloning and characterization of the ferric enterobactin receptor gene (pfeA) of Pseudomonas aeruginosa. J Bacteriol (1993) 1.74
Quorum-sensing and siderophore biosynthesis in Pseudomonas aeruginosa: lasR/lasI mutants exhibit reduced pyoverdine biosynthesis. FEMS Microbiol Lett (1998) 1.74
Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system. Antimicrob Agents Chemother (2000) 1.65
Cloning and sequence analysis of a gene (pchR) encoding an AraC family activator of pyochelin and ferripyochelin receptor synthesis in Pseudomonas aeruginosa. J Bacteriol (1993) 1.64
A critique of a UK standardized test of finger rewarming after cold provocation in the diagnosis and staging of hand-arm vibration syndrome. Occup Med (Lond) (2003) 1.47
PchR, a regulator of ferripyochelin receptor gene (fptA) expression in Pseudomonas aeruginosa, functions both as an activator and as a repressor. J Bacteriol (1996) 1.46
Pyochelin-mediated iron transport in Pseudomonas aeruginosa: involvement of a high-molecular-mass outer membrane protein. Infect Immun (1991) 1.41
Cocaine exposure is associated with subtle compromises of infants' and mothers' social-emotional behavior and dyadic features of their interaction in the face-to-face still-face paradigm. Dev Psychol (2005) 1.36
Influence of the TonB energy-coupling protein on efflux-mediated multidrug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1998) 1.36
Influence of the MexA-MexB-oprM multidrug efflux system on expression of the MexC-MexD-oprJ and MexE-MexF-oprN multidrug efflux systems in Pseudomonas aeruginosa. J Antimicrob Chemother (2000) 1.35
Phosphate transport in Pseudomonas aeruginosa. Involvement of a periplasmic phosphate-binding protein. Eur J Biochem (1984) 1.32
Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa. J Antimicrob Chemother (2000) 1.29
A second tonB gene in Pseudomonas aeruginosa is linked to the exbB and exbD genes. FEMS Microbiol Lett (2000) 1.25
Novel pyoverdine biosynthesis gene(s) of Pseudomonas aeruginosa PAO. Microbiology (1996) 1.22
Interaction of aminoglycosides with the outer membranes and purified lipopolysaccharide and OmpF porin of Escherichia coli. Antimicrob Agents Chemother (1991) 1.22
Iron release from transferrin by pyoverdin and elastase from Pseudomonas aeruginosa. Infect Immun (1994) 1.21
Expression of the ferric enterobactin receptor (PfeA) of Pseudomonas aeruginosa: involvement of a two-component regulatory system. Mol Microbiol (1993) 1.19
Epilepsy in the United Kingdom: seizure frequency and severity, anti-epileptic drug utilization and impact on life in 1652 people with epilepsy. Seizure (2004) 1.19
Lipopolysaccharide-free Escherichia coli OmpF and Pseudomonas aeruginosa protein P porins are functionally active in lipid bilayer membranes. J Bacteriol (1986) 1.19
The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively. Breast Cancer Res Treat (2001) 1.18
The MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa is growth-phase regulated. FEMS Microbiol Lett (1999) 1.17
The pvc gene cluster of Pseudomonas aeruginosa: role in synthesis of the pyoverdine chromophore and regulation by PtxR and PvdS. J Bacteriol (1999) 1.14
Influence of OprM expression on multiple antibiotic resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1997) 1.11
The enhancement of photodegradation efficiency using Pt-TiO2 catalyst. Chemosphere (2002) 1.10
Organic solvent-tolerant mutants of Pseudomonas aeruginosa display multiple antibiotic resistance. Can J Microbiol (1999) 1.10
Conservation of the multidrug resistance efflux gene oprM in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1997) 1.09
PfeR, an enterobactin-responsive activator of ferric enterobactin receptor gene expression in Pseudomonas aeruginosa. J Bacteriol (1996) 1.08
Mutational analysis of the OprM outer membrane component of the MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa. J Bacteriol (2001) 1.07
Copurification of the FpvA ferric pyoverdin receptor of Pseudomonas aeruginosa with its iron-free ligand: implications for siderophore-mediated iron transport. Biochemistry (1999) 1.06
Iron-free pyoverdin binds to its outer membrane receptor FpvA in Pseudomonas aeruginosa: a new mechanism for membrane iron transport. Mol Microbiol (2001) 1.03
Isolation of a Tn501 insertion mutant lacking porin protein P of Pseudomonas aeruginosa. Mol Gen Genet (1986) 1.02
The ferripyoverdine receptor FpvA of Pseudomonas aeruginosa PAO1 recognizes the ferripyoverdines of P. aeruginosa PAO1 and P. fluorescens ATCC 13525. FEMS Microbiol Lett (1999) 1.01
Fluoroquinolone susceptibilities of efflux-mediated multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia. J Antimicrob Chemother (2001) 0.96
Contribution of the MexAB-OprM multidrug efflux system to the beta-lactam resistance of penicillin-binding protein and beta-lactamase-derepressed mutants of Pseudomonas aeruginosa. J Antimicrob Chemother (1999) 0.95
Modification of the conductance, selectivity and concentration-dependent saturation of Pseudomonas aeruginosa protein P channels by chemical acetylation. Biochim Biophys Acta (1983) 0.94
Spatial and temporal trends of contaminants in Canadian Arctic freshwater and terrestrial ecosystems: a review. Sci Total Environ (1999) 0.92
The effect of hydroxyurea on the expression of the common fragile site at 3p14. J Med Genet (1987) 0.91
Three-dimensional reconstruction of the nu-AlCrFe phase by electron crystallography. Acta Crystallogr A (2003) 0.89
First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635. Eur J Pharmacol (1995) 0.88
A study of the preparation and reactivity of potassium ferrate. Chemosphere (2005) 0.87
Identification of Tomato Leaf Factors that Activate Toxin Gene Expression in Pseudomonas syringae pv. tomato DC3000. Phytopathology (1998) 0.87
The enhancement of TiO2 photocatalytic activity by hydrogen thermal treatment. Chemosphere (2003) 0.86
Levels of selenium, zinc, copper, and antioxidant enzyme activity in patients with leukemia. Biol Trace Elem Res (2006) 0.86
Respiratory function in survivors of the United Kingdom Extracorporeal Membrane Oxygenation Trial. Am J Respir Crit Care Med (2000) 0.86
Central and autonomic system signs with in utero drug exposure. Arch Dis Child Fetal Neonatal Ed (2002) 0.86
Association between early postnatal weight loss and death or BPD in small and appropriate for gestational age extremely low-birth-weight infants. J Perinatol (2007) 0.85
The effect of sleep deprivation on sleep states, breathing events, peripheral chemoresponsiveness and arousal propensity in healthy 3 month old infants. Eur Respir J (1996) 0.84
Synchronous primary pulmonary lymphoma presenting with pulmonary adenocarcinoma: A case report and literature review. Indian J Cancer (2015) 0.83
Expression and potential role of angiopoietins and Tie-2 in early development of the mouse metanephros. Dev Dyn (2001) 0.83
Insertion mutagenesis of the ferric pyoverdine receptor FpvA of Pseudomonas aeruginosa: identification of permissive sites and a region important for ligand binding. J Bacteriol (1998) 0.82
Unusual pheromone receptor neuron responses in heliothine moth antennae derived from inter-species imaginal disc transplantation. J Comp Physiol A Neuroethol Sens Neural Behav Physiol (2002) 0.82
The aqueous degradation of bisphenol A and steroid estrogens by ferrate. Water Res (2007) 0.81
The effect of 1-beta-D-arabinofuranosyl-cytosine on the expression of the common fragile site at 3p14. Hum Genet (1986) 0.81
Research-intensive cancer care in the NHS in the UK. Ann Oncol (2011) 0.80
[Alteration of permeability of bacterial envelope barrier in rifamdin-resistant Mycobacterium tuberculosis]. Hua Xi Yi Ke Da Xue Xue Bao (1988) 0.80
NHS services for epilepsy from the patient's perspective: a survey of primary, secondary and tertiary care access throughout the UK. Seizure (2000) 0.80
Identification of human N-ras as the common oncogene in NIH 3T3 cells transformed with DNAs from human primary hepatic cancer and hepatoma 7402 line. Sci Sin B (1986) 0.80
Information recalled by women taking anti-epileptic drugs for epilepsy: a questionnaire study. Epilepsy Res (2002) 0.79
Large scale production and semi-purification of kedarcidin in a 1000-L fermentor. J Ind Microbiol (1994) 0.79
Enhanced photocatalytic reduction reaction over Bi(3+)-TiO(2) nanoparticles in presence of formic acid as a hole scavenger. Chemosphere (2006) 0.79
Effect of alumina on photocatalytic activity of iron oxides for bisphenol A degradation. J Hazard Mater (2007) 0.79
Degradation of endocrine disrupting chemicals in aqueous solution by interaction of photocatalytic oxidation and ferrate (VI) oxidation. Water Sci Technol (2007) 0.79
An audit of recording cardiovascular risk factors in patients with rheumatoid arthritis and systemic lupus erythematosus in centres in East Anglia and the South East. Rheumatology (Oxford) (2008) 0.79
Phosphate-selective porins from the outer membranes of fluorescent Pseudomonas sp. Can J Microbiol (1987) 0.79
Exposure assessment in health assessments for hand-arm vibration syndrome. Occup Med (Lond) (2011) 0.79
Atherosclerotic cardiovascular mortality during the 1992 riots in Los Angeles. Am J Cardiol (1997) 0.79
Effects of a mixture of steam-flaked corn and extruded soybeans on performance, ruminal development, ruminal fermentation, and intestinal absorptive capability in veal calves. J Anim Sci (2013) 0.78
2,4-dichlorophenol degradation by an integrated process: photoelectrocatalytic oxidation and E-Fenton oxidation. Photochem Photobiol (2007) 0.78
The differences of serum cholesterol and lipoproteins in animals susceptible and nonsusceptible to atherosclerosis. Proc Chin Acad Med Sci Peking Union Med Coll (1990) 0.78
Kinetic modeling of electro-Fenton reaction in aqueous solution. Water Res (2007) 0.78
Neural-endocrine mechanisms of respiratory syncytial virus-associated asthma in a rat model. Genet Mol Res (2012) 0.77
Enhanced photocatalytic degradation of VOCs using Ln3+-TiO2 catalysts for indoor air purification. Chemosphere (2004) 0.77
A new human (psycho)pharmacology tool: the multiple organs coincidences counter (MOCC). J Psychopharmacol (1995) 0.77
The evolving role of the clinical nurse specialist within the comprehensive breast cancer centre. J Clin Nurs (1996) 0.76
Soluble CD30 as a prognostic factor for outcome following renal transplantation. J Clin Pathol (2009) 0.76
Characterization and Chemical Modification of Small Anion Specific Channels formed in Lipid Bilayer Membranes by Outer Membrane Protein P or Pseudomonas aeruginosa. Biophys J (1984) 0.75